Dr. Harsh Shah - Providing the Best HIPEC Treatment in Ahmedabad
Being diagnosed with cancer is often overwhelming, but having a skilled doctor for CRS+HIPEC treatment is crucial. Dr. Harsh Shah, a leading CRS+HIPEC specialist in Ahmedabad, brings over 15 years of experience in cancer treatment. Heβs renowned for successfully helping numerous patients in their fight against cancer, earning acclaim for his exceptional skills and empathetic approach to care.
Dr. Harsh Shah - Providing the Best HIPEC Treatment in Ahmedabad
Being diagnosed with cancer is often overwhelming, but having a skilled doctor for CRS+HIPEC treatment is crucial. Dr. Harsh Shah, a leading CRS+HIPEC specialist in Ahmedabad, brings over 15 years of experience in cancer treatment. Heβs renowned for successfully helping numerous patients in their fight against cancer, earning acclaim for his exceptional skills and empathetic approach to care.
Trained from the best
Maulana Azad Medical College, Delhi, GB Pant Hospital, Delhi
Highly qualified
Holds the highest degrees in Oncology - DrNB, MCh
Rich experience
Having 15+ years of experience in treating
Meet
Dr. Harsh Shah
Dr Harsh Shah is one of the leading CRS and HIPEC specialists in India. He has more than 15+ years of experience & treated hundreds of patients with CRS+HIPEC.
Β
The management of various types of cancer with the treatment of CRS+HIPEC involves prompt diagnosis & early treatment. The cancers treated are colorectal cancer, gastric cancer, pseudomyxoma peritonei, peritoneal mesothelioma & primary peritoneal serous carcinoma.
0
K +
Happy Patients
0
K +
Successful Surguries
0 +
Google Rating
11750+ Patients
11750+ Patients have been successfully
treated
15+ Years
15+ years of work experience as a liver cancer specialist
22+ Awards
22+ Awards received by Dr. Shah for his achievements
Expertise
+ Techniques
+ A pioneer
Expertise
Dr. Harsh Shah is a highly respected HIPEC specialist in Ahmedabad, known for his exceptional skills in treating cancers using CRS & HIPEC treatment. With over 15+ years of experience, he has become a leading doctor for CRS+HIPEC in Ahmedabad. Dr. Shahβs expertise lies in understanding the complexities of cancer and tailoring treatments to each patientβs needs. He has a deep commitment to providing the best possible care, which has led to successful outcomes for hundreds of patients. His knowledge and skill in this specialized field make him a trusted name in cancer treatment, not just in Gujarat, but across India.
Β
Dr. Shah, who studied at the Maulana Azad Medical College and GB Pant Hospital in Delhi, has gained in-depth expertise in CRS and HIPEC. He is dedicated to keeping himself updated with the newest medical developments. This commitment ensures that his patients get the most advanced and innovative treatments for these conditions.
+ Techniques
In terms of techniques, Dr. Shah is well-versed in the latest advancements in HIPEC surgery in India. His approach is patient-centric, focusing on minimally invasive methods to ensure quicker recovery and less discomfort for patients. The HIPEC treatment in Gujarat, led by Dr. Shah, utilizes state-of-the-art equipment and procedures, reflecting his commitment to providing top-tier medical care. His hospital in Ahmedabad is equipped to handle complex CRS+HIPEC operations, making it a go-to centre for this specialized treatment.
Β
Dr. Shahβs HIPEC procedure focuses on hyperthermic intraperitoneal chemotherapy (HIPEC), a high-pack surgery approach to treating advanced cancers. As a HIPEC specialist, he utilizes advanced methods, ensuring HIPEC surgery success rate aligns with international standards. Patients can view the HIPEC surgery video for detailed insights.
+ A pioneer
Dr. Harsh Shah is not just a doctor; heβs a pioneer in the field of HIPEC surgery in India. His hospital, a renowned HIPEC hospital in Ahmedabad, is among the few centers offering advanced CRS & HIPEC treatments in the country. He has been instrumental in bringing this advanced treatment approach to India, ensuring that the HIPEC surgery cost in India remains accessible to a wider range of patients. Through his efforts, patients from all over India and beyond have access to world-class cancer treatment right in Ahmedabad.
Β
As a leader in HIPEC surgery in India, Dr. Shahβs hospital offers comprehensive hipec chemo treatment options. The HIPEC surgery cost in India is structured to be accessible, reflecting his commitment to providing affordable care without compromising quality.
CRS+HIPEC Procedure for Cancer Treatment
CRS+HIPEC refers to the combination of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy, a specialized treatment used primarily for cancers located in the peritoneal cavity. This approach includes two components: CRS, where surgeons excise visible tumors, and HIPEC, which involves administering warm chemotherapy directly into the abdomen.
When Is CRS+HIPEC Used?
+ How it Works?
+ Benefits
When Is CRS+HIPEC Used?
CRS+HIPEC is typically used for cancers that have spread to the peritoneum but not to other distant organs. This includes certain types of colorectal cancer, stomach cancer, ovarian cancer, and mesothelioma, among others. Itβs particularly considered when the cancer is limited to the abdominal cavity and when the patient is in good overall health to withstand the rigours of the procedure.
+ How it Works?
How Does the HIPEC Treatment Work?
During HIPEC, after the cytoreductive surgery is completed and visible tumors are removed, the abdominal cavity is bathed in a heated chemotherapy solution.
Β
Β
The heat increases the effectiveness of the chemotherapy and aids in the destruction of microscopic cancer cells. This process also limits the systemic impact of chemotherapy, as the drugs are largely confined to the abdominal area.
The chemotherapy solution is usually heated to about 42Β°C (107.6Β°F) and circulated in the abdomen for up to 90 minutes before being drained.
Β
+ Benefits
Benefits of CRS+HIPEC over Traditional Treatments
CRS+HIPEC, which combines Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, presents notable benefits compared to conventional treatment methods:
1. It leads to higher survival rates, particularly effective for cancers within the peritoneal cavity.
2. Offers better local management by directly addressing tumor sites.
3. Minimizes overall toxicity in the body and results in reduced adverse effects.
4. Provides new avenues for treating cancers that were previously difficult to manage.
Our Happy Patients
- We are greatful to Dr harsh shah had done hipec surgery for my mother.
- we completely satisfied after surgery.
- I will always be grateful to you.
- I will never be able to repay this favor of yours.
- Dr harsh shah is best Gastro cancer surgeon in Ahmedabad, India.
- Thank you so much sir.
Babu Vanzara
- We are greatful to Dr harsh shah had done hipec surgery for my mother.
- we completely satisfied after surgery.
- I will always be grateful to you.
- I will never be able to repay this favor of yours.
- Dr harsh shah is best Gastro cancer surgeon in Ahmedabad, India.
- Thank you so much sir.
Babu Vanzara
4.9/5 based on 145 reviews
β
β
β
β
β
4.9/5
4.9/5 based on 145 reviews
β
β
β
β
β
4.9/5
Why choose Dr. Harsh Shah's HIPEC Treatment?
Team of experts
+ Infrastructure
+ Knowledge & Trust
Team of experts
At Dr. Harsh Shahβs HIPEC hospital in Ahmedabad, a dedicated team of experts works tirelessly to provide the best CRS & HIPEC treatment. This team, led by Dr. Shah, who is a renowned HIPEC specialist in Ahmedabad, includes skilled surgeons, knowledgeable oncologists, and caring nurses, all specialized in HIPEC treatment in Gujarat.
Β
Every member of the team has been carefully selected for their expertise in HIPEC surgery in India, ensuring that patients receive comprehensive care. This team approach is vital for the intricate CRS+HIPEC operation in India, as it requires a blend of specialized skills and coordinated efforts to ensure the best outcomes for patients.
Dr. Shah leads a team of HIPEC surgeons, skilled in delivering hyperthermic intraperitoneal chemotherapy efficiently. This team ensures the highest success rates for HIPEC treatment and is equipped with state-of-the-art technology for CRS+HIPEC procedures.
+ Infrastructure
In the Dr. Harsh Shahβs Esophageal cancer hospital, The operation theatre is equipped with latest robotic system, HD laparoscopy system, Laser system, Laminar flow β Hepafilter & many more such technologies.
Β
The Hospital also has 50+ bedded ICU with the latest support systems such as ventilators, dialysis machines & a team of best critical care doctors.
Radilogy department is fully equipped with latest CT Scan & MRI machines. The hospital also has an interventional radiology suit.
+ Knowledge & Trust
Dr. Harsh Shah has earned immense trust and respect as a leading HIPEC doctor in Ahmedabad. This trust stems from his deep knowledge of HIPEC and CRS treatments and his commitment to offering the most advanced care to his patients. He understands the concerns patients have, especially regarding HIPEC surgery cost in India, and strives to provide transparent and honest guidance.
Β
His extensive experience in HIPEC surgery in India, combined with his approachable nature, has made him not just a doctor but a trusted advisor to many of his patients. Dr. Shahβs dedication to staying abreast of the latest developments in his field further strengthens the trust patients place in him and his hospital.
Dr. Shahβs expertise as a renowned HIPEC specialist in Ahmedabad and Gujarat positions him as the best oncologist in Gujarat. His transparency about HIPEC treatment costs and outcomes strengthens the trust patients place in him and his hospital.
Surgical Photographs
Explore surgical photographs with caution. Please be advised that viewer discretion is recommended.
Conditions Treated with CRS+HIPEC
CRS+HIPEC has demonstrated encouraging outcomes in treating a range of cancers within the abdominal area. The following are some of the specific conditions where this advanced treatment method can be effectively applied:
HIPEC for Colorectal cancer
In the treatment of colorectal cancer, HIPEC plays a vital role. This method involves circulating warm chemotherapy in the abdomen during surgery. The elevated temperature boosts the chemotherapyβs effectiveness, specifically targeting residual cancer cells to lower the chance of the cancer returning.
HIPEC for Pseudomyxoma peritonei
For combating gastric cancer, which impacts the stomach, HIPEC is a key strategy. Post-surgical removal of the cancer, heated chemotherapy is applied within the abdominal area. The heat enhances the impact of the chemotherapy, improving the likelihood of eradicating any leftover cancerous cells.
HIPEC for Gastric cancer
HIPEC is a standard treatment for Pseudomyxoma Peritonei, an uncommon cancer starting in the appendix or ovary and spreading to the abdominal lining. The procedure entails administering heated chemotherapy into the peritoneal cavity after tumor removal, a critical step in eradicating residual cancer and preventing cancerβs return.
Latest Updates in HIPEC
Frequently Asked Questions
Yes, cashless treatment is available for HIPEC (Hyperthermic Intraperitoneal Chemotherapy), providing specialized care with minimal financial stress. Visit our Insurance Page for more details.
Specialized surgical oncologists or teams proficient in HIPEC often conduct this surgery.
HIPEC offers several advantages:
β’ Direct chemotherapy administration to the abdominal area.
β’ Enhanced chemotherapy efficacy due to heat application.
β’ Improved effectiveness in removing tumors during surgery.
β’ Lower chance of cancer returning.
β’ Possible increase in survival rates for certain advanced abdominal cancers.
Studies have shown that for certain cancers, CRS-HIPEC can significantly prolong survival compared to traditional treatments. For example, in cases of peritoneal mesothelioma, median survival rates can extend beyond 50 months with this treatment, compared to less than 12 months with traditional chemotherapy alone. In ovarian cancer, CRS-HIPEC has been shown to improve survival rates, particularly in patients with a small volume of disease.
Typically, patients can expect the following in terms of recovery:
1. Hospital Stay: Patients usually stay in the hospital for 7 to 14 days post-surgery. This duration can be longer if there are complications.
2. Initial Recovery: The first few weeks after discharge are often the most challenging. Patients may experience fatigue, discomfort, and limitations in physical activity. Complete healing from surgery may take several weeks.
3. Full Recovery: Full recovery can take anywhere from 6 weeks to a few months. During this period, patients gradually regain their strength and return to their normal activities. The timeline can vary based on the individualβs health status and the complexity of the surgery.
The survival rate for patients undergoing Cytoreductive Surgery (CRS) combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) depends on various factors including the type of cancer being treated, the stage of the disease, the patientβs overall health, and the completeness of the tumor removal during surgery.
Here are some general survival rate statistics for different types of cancers treated with CRS-HIPEC:
1. Peritoneal Mesothelioma: For patients with peritoneal mesothelioma, CRS-HIPEC has significantly improved survival rates. Median survival times of 40 to 92 months have been reported, which is a considerable improvement over traditional chemotherapy treatments.
2. Colorectal Cancer with Peritoneal Metastasis: In cases of colorectal cancer with peritoneal metastasis, the median survival with CRS-HIPEC treatment ranges from 30 to 63 months, compared to 12 to 24 months with systemic chemotherapy alone.
3. Ovarian Cancer: For advanced ovarian cancer, especially when the disease is limited to the peritoneal cavity, CRS-HIPEC has shown improved survival rates. Median survival times range from 30 to 45 months, which is higher compared to standard treatment.
4. Gastric Cancer with Peritoneal Spread: In gastric cancer with peritoneal dissemination, CRS-HIPEC can offer a median survival of about 12 to 31 months, a significant improvement over the median survival with systemic chemotherapy alone.
5. Pseudomyxoma Peritonei: This rare condition often responds well to CRS-HIPEC, with reported 5-year survival rates exceeding 80% in some studies.
Hyperthermic Intraperitoneal Chemotherapy (HIPEC) is a specialized treatment used primarily for cancers that have spread to the lining of the abdominal cavity, known as the peritoneum. The types of cancers that are commonly treated with HIPEC include:
1. Peritoneal Mesothelioma: A rare cancer that develops in the lining of the abdomen and is often associated with asbestos exposure.
2.Ovarian Cancer: HIPEC is used particularly in advanced stages where the cancer has spread within the abdominal cavity.
3. Colorectal Cancer: Itβs used for colorectal cancer that has spread to the peritoneum, especially when the metastasis is limited to the abdominal cavity.
4. Gastric Cancer: In cases where gastric cancer has spread to the peritoneum, HIPEC can be considered as a treatment option.
5. Appendiceal Cancer: Including pseudomyxoma peritonei, a condition often associated with appendiceal tumors.
6. Other Gastrointestinal Cancers: Such as certain types of pancreatic, small bowel, and hepatobiliary cancers, in cases where they have metastasized to the peritoneum.
7. Primary Peritoneal Cancer: A rare cancer that originates in the peritoneum itself.
8. Selected Sarcomas: Including some cases of sarcoma that have spread to the peritoneal surface.
OncoBot